Matthew C Kapusta sold $362k of QURE
CEO, Managing Director at uniQure N.V.. 33,444 shares at an average of $10.82, traded Feb 25, 2025, filed Feb 27, 2025.
Score components
- +25RoleCEO
- +15Trade size$362k at market
- 0Share of holdings soldSold 5.6% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +3.3%, 3m +23.4%, 6m +34.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000904454-25-000167, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 25, 2025 | SOpen-market sale Ordinary Shares | -26,727 | $10.70 | $286k | 571,188 | Feb 27, 2025 |
| Feb 26, 2025 | AGrant or award Ordinary Shares | +16,324 | $0.00 | $0 | 587,512 | Feb 27, 2025 |
| Feb 27, 2025 | SOpen-market sale Ordinary Shares | -6,717 | $11.32 | $76k | 580,795 | Feb 27, 2025 |
Related signals
Other insiders at uniQure N.V. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | uniQure N.V. | Walid Abi-Saab Chief Medical Officer | $67k 1,434 shares | -1% | |
| 30Weak | uniQure N.V. | Matthew C Kapusta CEO, Managing Director | $1.8M 35,412 shares | -7% | |
| 18Weak | uniQure N.V. | Madhavan Balachandran director | $526k 11,685 shares | -21% | |
| 40Moderate | uniQure N.V. | Matthew C Kapusta CEO, Managing Director | $9.4M 206,100 shares | -28% | |
| 13Weak | uniQure N.V. | Jack Kaye director | $225k 5,295 shares | -17% | |
| 14Weak | uniQure N.V. | Madhavan Balachandran director | $279k 10,000 shares | -19% | |
| 37Weak | uniQure N.V. | Madhavan Balachandran director | $54k 1,993 shares | -4% | |
| 18Weak | uniQure N.V. | Robert Gut director | $270k 10,278 shares | -29% | |
| 37Weak | uniQure N.V. | Rachelle Suzanne Jacques director | $54k 1,993 shares | -6% | |
| 37Weak | uniQure N.V. | Jack Kaye director | $54k 1,993 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.